SMS Pharmaceuticals is currently trading at Rs. 109.70, up by 10.10 points or 10.14% from its previous closing of Rs. 99.60 on the BSE.
The scrip opened at Rs. 104.90 and has touched a high and low of Rs. 114.30 and Rs. 103.00 respectively. So far 99,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 120.90 on 22-Sep-2017 and a 52 week low of Rs. 66.60 on 11-Aug-2017.
Last one week high and low of the scrip stood at Rs. 114.30 and Rs. 92.50 respectively. The current market cap of the company is Rs. 928.63 crore.
The promoters holding in the company stood at 67.99%, while Institutions and Non-Institutions held 0.04% and 31.97% respectively.
SMS Pharmaceuticals has successfully completed its fifth US Food and Drug Administration (US FDA) inspection for its manufacturing facility Unit-II located at Plot No.24 & 24B and 36 & 37, S V Co-operative Industrial Estate, Bachupally, Ranga Reddy District, Hyderabad in state of Telangana. There were no 'Form 483' observations issued during the inspection.
SMS Pharmaceuticals is a global player in API manufacturing having strong research and manufacturing team supported by state of art facilities. They are the single largest producer of anti-ulcer products.